Moscow, Russia, April 8, 2011: GE Healthcare, a unit of General Electric Company (NYSE: GE), SC Russian Technologies, and Meditsinskie Technologii Ltd (MTL) today presented Russia's first mass production facility for the assembly of high-tech computed tomography (CT) scanners to Prime Minister Vladimir Putin, via live video feed.
Novation member hospitals will have access to entire GE Healthcare portfolio of state-of-the-art CT medical imaging equipment
Waukesha, WI JAN 14, 2011 -- GE Healthcare said today it has entered into a three-year agreement with Novation LLC, one of the nation's largest group purchasing organization of medical equipment, that allows Novation's member hospitals to purchase GE's state-of-the-art CT imaging equipment.
business unit
tags
GE-exclusive ASiR and next generation technology to provide outstanding low-dose options for customers
CHICAGO--30 November 2010-- For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.
business unit
tags
Technologies foster better, more efficient care with improvements in image quality, dose management and clinician workflow
CHICAGO--28 November 2010-- Increasing access. Improving quality and efficiency. Lowering costs. When GE launched its healthymagination initiative last year, these were the long-term goals and at RSNA 2010, GE Healthcare will highlight a variety of technologies developed to support this strategy and help improve patient care worldwide.
business unit
tags
Remotely identifies and resolves small performance issues, for seamless operation
Data-driven prediction tools forecast maintenance needs, allowing customers to minimize unplanned downtime by scheduling required maintenance
Available only with the new AssurePoint Rapid and AssurePoint Performance service offerings
Service supported by GE's IMV top-ranked nuclear medicine and PET service teams
business unit
tags
- Iobenguane I 123 Injection Studied for Its Ability to Identify Risk in Patients with Symptomatic Heart Failure (HF)
PRINCETON, NJ, May 17, 2010 --The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) trial, the results of which were published in the May 18th, 2010 issue of the Journal of the American College of Cardiology, is a prospective study evaluating cardiac sympathetic nerve imaging using Iobenguane I 123 Injection (AdreView™) for identifying symptomatic heart failure patients most likely t